跳至主要内容
临床试验/NCT04026282
NCT04026282Unknown不适用

A Prospective, Randomized Controlled Study to Investigate the CLBRs of GnRH Antagonist Protocol Compared With the Standard GnRH Agonist Long Protocol for Controlled Ovarian Stimulation in Supposed Normal Ovarian Responders

Peking University Third Hospital4 个研究点 分布在 1 个国家目标入组 888 人开始时间: 2018年12月27日最近更新:
适应症

试验速览

阶段
不适用
入组人数
888
试验地点
4
主要终点
the cumulative live birth rates

研究概览

简要总结

This is a Phase IV, prospective, randomized controlled study to investigate the cumulative live birth rates (CLBRs) of gonadotrophin-releasing hormone (GnRH) antagonist protocol (GnRH-ant group) compared with the standard GnRH agonist long protocol (GnRH-a group) for controlled ovarian stimulation in supposed normal ovarian responders.

详细描述

This is a Phase IV, prospective, randomized controlled study to investigate the cumulative live birth rates (CLBRs) of gonadotrophin-releasing hormone (GnRH) antagonist protocol (GnRH-ant group) compared with the standard GnRH agonist long protocol (GnRH-a group) for controlled ovarian stimulation in supposed normal ovarian responders.

In this study, patients who are planning to undergo IVF/ICSI cycle aged ≤38 years old with normal ovarian reserve will be considered for enrollment. Approximately 888 patients will be enrolled at approximately 5 centers in China over a period of 10 months.

About 12-20 visits will be performed in this study for each patient. The CLBR with first live birth resulting from one initiated COS cycle will be compared between GnRH-a group and GnRH-ant group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertile women planning to undergo IVF/ICSI cycle using conventional GnRH agonist long protocol or GnRH antagonist protocol
  • Age ≤ 38 years old
  • Basal AFC 8~20
  • Basal FSH≤10 IU/L
  • Basal E 2 <200pmol/L
  • Normal uterus and at least one side of the normal ovary
  • Informed consent form signed
  • Willing to follow the study protocol, and able to complete this study

排除标准

  • Previous IVF/ICSI cycles >2
  • Severe hydro-salpinx (Ultrasound shows hydro salpinx﹥2cm)
  • Severe endometriosis (Grade III - IV)
  • Polycystic ovarian syndrome (PCOS)
  • History of recurrent miscarriages (>2 times of miscarriages)
  • Plan to undergo ovarian stimulation for preimplantation genetic diagnosis or preimplantation genetic screening, oocyte donation, and social or medical freezing of oocytes
  • Any major systemic disease that as per Investigator's discretion precludes subject for participation in the study
  • With pregnancy contraindications
  • Alcoholism, drug abuse, drug addiction or patients with uncured sexually transmitted disease
  • According to the judgment of the Investigator, any medical condition or any concomitant surgery/medications that would interfere with evaluation of study medications
  • Simultaneous participation in another clinical study
  • Plan to use urinary gonadotrophin during COS treatment

结局指标

主要结局

the cumulative live birth rates

时间窗: two years

To investigate the cumulative live birth rates in infertile women ≤ 38 years old with normal ovarian from one initiated COS cycle. reserve using GnRH antagonist or agonist protocol for COS in ART treatment Numerator is the No. of women got their first live birth, the Denominator is the No. of women who attempt the ovarian stimulation. There will be two ways to calculate the CLBR: * The conservative estimate of the cumulative live birth rate, which is based on the assumption that none of the women who do not return for a subsequent embryo transfer would have had a live birth. * The optimal estimate of the cumulative live birth rate, which is based on the assumption that women who do not return for a subsequent embryo transfer would have had the same live birth rates as those who do return.

次要结局

  • Good-quality embryo rate (The Istanbul Consensus29)(24 hours after Oocytes pick up)
  • Rate of OHSS(two weeks after Oocytes pick up)
  • Number of oocytes retrieved(24 hours after Oocytes pick up)
  • hCG positive rate(after 11 to 17 days of ET)
  • Implantation rate(4 to 6 weeks after ET)
  • Ongoing pregnancy rate(after 12 weeks of ET)
  • Cumulative clinical pregnancy rate(two years)
  • Clinical pregnancy rate(after 4 to 6 weeks of ET)
  • Live birth rate(two years)
  • Miscarriage rate(after 12 weeks of ET)
  • Cycle cancelled rate and reason(On ART cycle)
  • Time to pregnancy(4 to 6 weeks after ET)
  • Ectopic pregnancy rate(after 4 to 6 weeks of ET)
  • severity of OHSS(two weeks after Oocytes pick up)
  • Time to live birth(nine months after pregnancy)
  • the Safety(Two years after signature of informed consent)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jie Qiao

Professor

Peking University Third Hospital

研究点 (4)

Loading locations...

相似试验

已完成
4 期
A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A VaccineVaricella
NCT05526820Sinovac (Dalian) Vaccine Technology Co., Ltd.450
已完成
不适用
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)Idiopathic Parkinson Disease
NCT03944785Supernus Pharmaceuticals, Inc.164
进行中(未招募)
1 期
Multicenter clinical trial to evaluate the efficacy of a preventive strategy against CMV infection in heart transplant patients, based on T cells responses.We will investigate the benefits of monitoring the CMV-specific cellular response using the ELISPOT INF-y technique in patients with a positive serology against CMV, allowing the individualization of the preventión strategy. The drugs valganciclovir and ganciclovir will be used in seropositive patitens (IgG against CMV), not indicated in the data sheet but accepted as part of the habitual prophylaxis of heart transplant patient according to the clinical practice guidelines.MedDRA version: 20.0 Level: LLT Classification code 10058666 Term: Cytomegalovirus infection reactivation System Organ Class: 100000004862
EUCTR2019-002233-11-ESDr. José González Costello.Unidad de Insuficiencia cardíaca avanzada y Trasplante cardíaco. Hospital Univ. Bellvitge188
已完成
4 期
Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.Astigmatism
NCT01885780Technolas Perfect Vision GmbH45
已完成
不适用
Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive ImpairmentType 2 Diabetes MellitusMild Cognitive Impairment
NCT06327633The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School60